Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. read more
Daniel Stoner ā Chief Financial Officer at Nephron Pharmaceuticals
Executive Bio
Daniel Stoner serves as the Chief Financial Officer of Nephron Pharmaceuticals. Daniel started at Nephron Pharmaceuticals in September of 2018. Daniel currently resides in the Columbia, South Carolina Area.
Chief Financial Officer Impact on Finance Department's Culture
Daniel Stoner holds the highest position within the Finance department at Nephron Pharmaceuticals ā Chief Financial Officer, and therefore has influence on the culture of the Finance department.
Are you challenged at work?
Are your company's goals clear, and are you invested in them?
Are you satisfied with your work/life balance?
Is your work environment positive or negative?
How would you rate the value & quality of meetings at your company?
Does your current company provide you meaningful opportunities for career advancement?
Executive Team Culture Ratings from Nephron Pharmaceuticals Employees
BOTTOM
5%
Nephron Pharmaceuticals' Executive Team scores in the Bottom 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Nephron PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Nephron PharmaceuticalsNephron Pharmaceuticals' Executive Team at a Glance
Based on 12 ratings, Nephron Pharmaceuticals' employees are less satisfied with their Executive Team and give them a āFā or 45/100.
Nephron Pharmaceuticals' Executive Team ranks in the Bottom 5% of other companies in New York and Bottom 5% of other companies on Comparably that also have 501-1,000 Employees.
×